• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶血磷脂酸受体-2(LPA)和溶血磷脂酸对结肠癌细胞化疗耐药性调节的不同作用。

Different effects of lysophosphatidic acid receptor-2 (LPA) and LPA on the regulation of chemoresistance in colon cancer cells.

作者信息

Ishimoto Kaichi, Minami Akito, Minami Kanako, Ueda Nanami, Tsujiuchi Toshifumi

机构信息

Division of Molecular Oncology, Department of Life Science, Faculty of Science and Engineering, Kindai University, Higashiosaka, Osaka, Japan.

出版信息

J Recept Signal Transduct Res. 2021 Feb;41(1):93-98. doi: 10.1080/10799893.2020.1794002. Epub 2020 Jul 16.

DOI:10.1080/10799893.2020.1794002
PMID:32672083
Abstract

Lysophosphatidic acid (LPA) is a simple physiological lipid and exhibits several biological functions by binding to G-protein-coupled LPA receptors (LPA receptor-1 (LPA) to LPA). The present study aimed to evaluate whether LPA signaling LPA and LPA is involved in the chemoresistance to anticancer drugs in colon cancer DLD1 cells. In cell survival assay, cells were treated with fluorouracil (5-FU) every 24 h for 2 days. The cell survival rate to 5-FU of DLD1 cells was significantly decreased by LPA treatment. In the presence of LPA, the cell survival rate to 5-FU was significantly elevated by LPA knockdown. Before initiation of the cell survival assay, cells were pretreated with an LPA agonist, GRI-977143. The cell survival rate to 5-FU was markedly increased in DLD1 cells treated with GRI-977143. In the presence of GRI-977143, the elevated cell survival rate of DLD1 cells was reduced by LPA knockdown. To assess the effects of LPA and LPA on the enhancement of chemoresistance, long-term 5-FU treated (DLD-5FU) cells were generated from DLD1 cells. The cell survival rate to 5-FU of DLD-5FU cells were significantly elevated by LPA knockdown. GRI-977143 treatment increased the cell survival rate to 5-FU of DLD-5FU cells. These results suggest that LPA promotes and LPA suppresses the acquisition of chemoresistance in colon cancer cells treated with anticancer drugs.

摘要

溶血磷脂酸(LPA)是一种简单的生理性脂质,通过与G蛋白偶联的LPA受体(从LPA受体-1(LPA1)到LPA6)结合发挥多种生物学功能。本研究旨在评估LPA信号通路中的LPA1和LPA3是否参与结肠癌DLD1细胞对抗癌药物的化疗耐药性。在细胞存活试验中,细胞每24小时用氟尿嘧啶(5-FU)处理2天。LPA处理显著降低了DLD1细胞对5-FU的细胞存活率。在存在LPA的情况下,LPA基因敲低显著提高了对5-FU的细胞存活率。在细胞存活试验开始前,细胞用LPA激动剂GRI-977143预处理。用GRI-977143处理的DLD1细胞对5-FU的细胞存活率显著增加。在存在GRI-977143的情况下,LPA基因敲低降低了DLD1细胞升高的细胞存活率。为了评估LPA1和LPA3对化疗耐药性增强的影响,从DLD1细胞中生成了长期5-FU处理的(DLD-5FU)细胞。LPA基因敲低显著提高了DLD-5FU细胞对5-FU的细胞存活率。GRI-977143处理增加了DLD-5FU细胞对5-FU的细胞存活率。这些结果表明,LPA1促进而LPA3抑制在用抗癌药物处理的结肠癌细胞中获得化疗耐药性。

相似文献

1
Different effects of lysophosphatidic acid receptor-2 (LPA) and LPA on the regulation of chemoresistance in colon cancer cells.溶血磷脂酸受体-2(LPA)和溶血磷脂酸对结肠癌细胞化疗耐药性调节的不同作用。
J Recept Signal Transduct Res. 2021 Feb;41(1):93-98. doi: 10.1080/10799893.2020.1794002. Epub 2020 Jul 16.
2
Effects of LPA and LPA on the regulation of colony formation activity in colon cancer cells treated with anticancer drugs.溶血磷脂酸(LPA)对经抗癌药物处理的结肠癌细胞集落形成活性调节的影响。 你提供的原文中重复出现了“LPA and LPA”,我按照常规理解进行了翻译,若你有其他特殊要求,请随时告知。
J Recept Signal Transduct Res. 2018 Feb;38(1):71-75. doi: 10.1080/10799893.2018.1426608.
3
Lysophosphatidic acid receptor-2 (LPA)-mediated signaling enhances chemoresistance in melanoma cells treated with anticancer drugs.溶血磷脂酸受体-2(LPA)介导的信号通路增强了接受抗癌药物治疗的黑色素瘤细胞的耐药性。
Mol Cell Biochem. 2020 Jun;469(1-2):89-95. doi: 10.1007/s11010-020-03730-w. Epub 2020 Apr 16.
4
Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA in melanoma cells treated with anticancer drugs.通过在接受抗癌药物治疗的黑素瘤细胞中 LPA 信号对溶脂性磷脂酸(LPA)的化学耐药性进行调节。
Biochem Biophys Res Commun. 2019 Sep 17;517(2):359-363. doi: 10.1016/j.bbrc.2019.07.092. Epub 2019 Jul 27.
5
Effects of lysophosphatidic acid (LPA) receptor-2 (LPA) and LPA on the regulation of chemoresistance to anticancer drug in lung cancer cells.溶血磷脂酸(LPA)受体-2(LPA)和 LPA 对肺癌细胞对抗癌药物化疗耐药性的调节作用。
Cell Signal. 2020 May;69:109551. doi: 10.1016/j.cellsig.2020.109551. Epub 2020 Feb 4.
6
Lysophosphatidic acid (LPA) signaling via LPA and LPA negatively regulates cell motile activities of colon cancer cells.溶血磷脂酸(LPA)通过LPA信号通路对结肠癌细胞的细胞运动活性起负向调节作用。
Biochem Biophys Res Commun. 2017 Jan 29;483(1):652-657. doi: 10.1016/j.bbrc.2016.12.088. Epub 2016 Dec 18.
7
Impact of cellular ATP levels on cell viability in response to fluorouracil through lysophosphatidic acid (LPA) receptor-4 (LPA) and LPA in colon cancer cells.细胞内 ATP 水平对氟尿嘧啶通过溶血磷脂酸(LPA)受体-4(LPA)和 LPA 对结肠癌细胞活力的影响。
Adv Biol Regul. 2024 Aug;93:101042. doi: 10.1016/j.jbior.2024.101042. Epub 2024 Jul 16.
8
Cooperation of G12/13 and Gi proteins via lysophosphatidic acid receptor-2 (LPA) signaling enhances cancer cell survival to cisplatin.G12/13 和 Gi 蛋白通过溶血磷脂酸受体-2(LPA)信号增强了癌细胞对顺铂的存活能力。
Biochem Biophys Res Commun. 2020 Nov 12;532(3):427-432. doi: 10.1016/j.bbrc.2020.08.087. Epub 2020 Aug 31.
9
Induction of lysophosphatidic acid (LPA) receptor-mediated signaling regulates cell motility and survival to anticancer drugs in cancer cells treated with hydrogen peroxide.过氧化氢处理的癌细胞中溶血磷脂酸(LPA)受体介导的信号转导诱导可调节细胞运动性和对抗癌药物的存活能力。
Adv Biol Regul. 2023 Aug;89:100978. doi: 10.1016/j.jbior.2023.100978. Epub 2023 Aug 18.
10
Autotaxin and LPA1 and LPA5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasis.自分泌运动因子以及溶血磷脂酸1和溶血磷脂酸5受体在黑色素瘤侵袭和转移过程中,在肿瘤细胞与宿主组织微环境中发挥不同的功能。
Mol Cancer Res. 2015 Jan;13(1):174-85. doi: 10.1158/1541-7786.MCR-14-0263. Epub 2014 Aug 26.

引用本文的文献

1
The Emerging Role of LPA as an Oncometabolite.LPA 作为一种致癌代谢物的新兴作用。
Cells. 2024 Apr 4;13(7):629. doi: 10.3390/cells13070629.
2
Small molecule inhibitors for cancer metabolism: promising prospects to be explored.小分子抑制剂在癌症代谢中的应用:具有广阔前景的探索。
J Cancer Res Clin Oncol. 2023 Aug;149(10):8051-8076. doi: 10.1007/s00432-022-04501-4. Epub 2023 Mar 31.
3
gene and autotaxin-lysophosphatidic acid axis in gastrointestinal cancers.胃肠道癌症中的基因与自分泌运动因子-溶血磷脂酸轴
World J Gastrointest Oncol. 2022 Aug 15;14(8):1388-1405. doi: 10.4251/wjgo.v14.i8.1388.
4
LPAR2-mediated action promotes human renal cell carcinoma via MAPK/NF-κB signaling to regulate cytokine network.LPAR2介导的作用通过MAPK/NF-κB信号通路促进人肾细胞癌,以调节细胞因子网络。
J Cancer Res Clin Oncol. 2023 May;149(5):2041-2055. doi: 10.1007/s00432-022-04197-6. Epub 2022 Jul 20.
5
Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials.溶血磷脂酸受体拮抗剂与癌症:当前趋势、临床意义和试验。
Cells. 2021 Jun 29;10(7):1629. doi: 10.3390/cells10071629.